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AbsTrACT
Objectives Complications from sexually transmitted 
infections (STIs) can result in severe morbidity and 
mortality. To date, no STI population studies have 
been conducted on the Bijagos Islands, Guinea Bissau. 
Our objective was to estimate the prevalence of and 
identify risk factors for Chlamydia trachomatis (Ct), 
Neisseria gonorrhoea (Ng), Mycoplasma genitalium (Mg), 
Trichomonas vaginalis (Tv) and Treponema pallidum (Tp) 
on Bubaque, the most populated island.
Methods A cross- sectional survey was conducted on 
the island of Bubaque among people aged 16–49 years. 
Participants were asked to answer a questionnaire on STI 
risk factors, to provide urine samples (men and women) 
and vaginal swabs (women) for PCR testing for Ct, Ng, 
Mg and Tv, and to provide dry blood spots for Tp particle 
agglutination assays. Data were analysed to estimate the 
prevalence of STIs and logistic regression was used to 
identify risk factors.
results In total, 14.9% of participants were found 
to have a curable STI, with the highest prevalence 
being observed for Tv (5.9%) followed by Ct (3.8%), 
Ng (3.8%), Mg (1.9%) and Tp (0.8%). Significant risk 
factors for having any STI included being female, younger 
age and concurrent partnership. Having had a previous 
STI that was optimally treated was a protective factor.
Conclusions This study demonstrates that there is 
a considerable burden of STI on the Bijagos Islands, 
stressing the need for diagnostic testing to facilitate 
early detection and treatment of these pathogens to stop 
ongoing transmission. Moreover, these results indicate 
the need to conduct further research into the STI burden 
on the Bijagos Islands to help inform and develop a 
national STI control strategy.
InTrOduCTIOn
An estimated 357 million cases of curable sexu-
ally transmitted infections (STIs) occur each year 
worldwide.1 Chlamydia trachomatis (Ct), Neis-
seria gonorrhoea (Ng), Trichomonas vaginalis (Tv) 
and Treponema pallidum (Tp) account for a large 
proportion of these1 and, more recently, Myco-
plasma genitalium (Mg) has been recognised as a 
significant STI.2 Although often initially asymp-
tomatic, complications from these curable STI can 
result in severe morbidity and mortality.3–5
STIs disproportionately affect low- income coun-
tries and prevalence estimates are usually higher for 
women.6 As laboratory‐based testing is frequently 
unavailable in low- income countries, STIs are usually 
treated through syndromic management.6 However, 
most STIs remain asymptomatic constituting a large 
reservoir for ongoing infection. Moreover, when 
left undiagnosed and untreated these can result in 
complications including pelvic inflammatory disease 
that can lead to infertility, ectopic pregnancy, miscar-
riage and stillbirth in women and epididymo- orchitis 
and subsequent subfertility in men.4 The inability 
to detect asymptomatic infections using laboratory- 
based diagnostics also limits the availability of epide-
miological data that can help to better understand the 
burden of STI. Studies are therefore needed to under-
stand STI transmission so that targeted intervention 
and control programmes can be developed to reduce 
the burden of infection.6
Guinea Bissau is one of the least- developed coun-
tries in the world.7 Data on the prevalence of curable 
STI and their risk factors are scarce. STI research 
in Guinea Bissau has largely focused on selected 
groups, including women with urogenital symp-
toms,8–10 women giving birth at the National Referral 
Hospital,11 the police12 and military professionals,13 
providing little information on STI in the general 
population.
The Bijagos Islands lie off the coast of Guinea 
Bissau; no data on STI are available for this region. The 
population is highly mobile, has matriarchal elements 
to its structure and people continue to follow tradi-
tional religious practices.14 15 These unusual cultural 
aspects mean that sexual behaviour, patterns of STI 
transmission and health- seeking behaviour, may not 
be typical. Furthermore, the Bijagos Islands have been 
a site for mass drug administration (MDA) with azith-
romycin for trachoma control.16 Azithromycin is an 
antibiotic that is effective against a number of STI17; 
however, the impact of MDA on STI prevalence is 
not known in this setting.
Here, we conducted a cross- sectional study of STI 
prevalence on Bubaque, the most populated of the 
Bijagos islands of Guinea Bissau. We aimed to esti-
mate the prevalence of Ct, Ng, Mg, Tv and Tp and to 
identify risk factors associated with these infections.
MeThOds
ethical approvals
This study was conducted in accordance with the 
declaration of Helsinki. Ethical approvals were 
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Figure 1 Flowchart indicating the number of participants included in data analysis from the study population.
given by the Comitê Nacional de Ética e Saúde, Guinea Bissau (ref 
022) and the ethics committee of the London School of Hygiene 
and Tropical Medicine (LSHTM) (ref 11701). Written consent 
(signature or a thumb print) was provided by all participants.
study design
A cross- sectional study of people aged between 16 and 49 living 
on Bubaque Island, Guinea Bissau was conducted over a 12week 
period in 2016.
A target sample size of 500 participants was calculated to give 
sufficient power based on an estimated prevalence of urogen-
ital Ctt of 10% in adults, a 95% CI of 1.96 (α=5%), a degree 
of absolute precision of 3% (d=0.03) and a design effect for 
cluster surveys taken from previous urogenital chlamydia studies 
of 1.26.18 It was estimated that 150 households were needed to 
recruit 500 participants.
A probability- proportional- to- size sampling method was used, 
with the number of households randomly selected from each of 
the 23 villages weighted by population size. Eligibility criteria 
included age between 16 and 49 years, capacity to consent and 
ability to provide samples.
data collection
Trained fieldworkers used a structured questionnaire to conduct 
private interviews on socioeconomic factors (religion, education, 
income and marital status), sexual history (age of sexual debut, 
number of partners in 1 year, concurrent partners, previous 
STI and their treatment, contraception use, condom use) and 
symptoms (genital ulcer, urethral discharge or dysuria in men, 
and genital ulcer, vaginal discharge or lower abdominal pain 
in women). Participants reporting STI symptoms were referred 
to the local hospital for syndromic management. Participants 
provided dry blood spots (DBS) and urine samples and women 
also provided two self- taken high vaginal swabs (HVS) taken 
under nurse- guidance. Dry samples were stored on Bubaque at 
4°C for a maximum period of 1 month until transfer to Bissau 
(−20°C) and then to the LSHTM, London (−80°C).
Laboratory procedures
The BioChain DNA isolation kit (catalogue no. K5017100) was 
used to extract DNA from urine samples (men and women) 
and HVS (women) following the manufacturer's recommenda-
tions. Primer sets were adapted from the AmpliSens multiplex 
real- time PCR, which simultaneously detected Ct, Ng, Mg and 
Tv.19 PCR primer concentrations were optimised for the Rotor- 
GeneTM 3000 platform and diagnostic validity was assessed using 
a panel of known- positive and negative samples of the 4 STI 
(Qnostics STI Evaluation Panel 01). The assay was then applied 
to all extracted DNA samples. A single positive sample defined 
an individual as having that STI.
DBS were tested using the Tp particle agglutination assay 
(TPPA, Fujirebio, Tokyo, Japan), according to the manufactur-
er’s protocol. Positive and negative controls were included in 
each plate. The results were interpreted by two technicians inde-
pendently. Samples with discordant and/or indeterminate results 
were repeated. Repeated samples that gave indeterminate results 
were excluded from further analysis.
data analyses
STATA (V.15.1, StataCorp) was used to calculate STI prevalence, 
to perform statistical tests and multivariable regressions to deter-
mine risk factors for STI.
First, a logistic regression model of STI infection status and 
village was performed to determine if multivariable regression 
would need to be adjusted for the cluster sample methodology. 
Univariable logistic regression models of STI status and each 
potential risk factor were performed (adjusted for age and sex). 
Risk factors with p<0.10 in the univariable analysis were entered 
into a multivariable model. Risk factors with p<0.05 in the final 
model were deemed to be independent risk factors for STI.
resuLTs
Participant characteristics
Between May and July 2016, 518 participants from 150 house-
holds were enrolled into the study. Complete biological sample 
and epidemiological data (figure 1) were available for 478/518 
(92%) participants, which was used to asses risk factors associ-
ated with having an STI. The median age of participants was 24 
years (range: 16–59) and 59.2% of participants were women. 
The majority of participants (60.5%) had been to secondary 
school, 62.7% earned an income and 87.5% were married. On 
average, female participants had had 2.6 pregnancies and 21.6% 
of women were pregnant at the time of the study. Sexual debut 
had occurred under the age of 16 for 32.8% of participants. Of 
the 7.9% of participants who reported never having had sex, five 
were found to have an STI. A significant proportion of partici-
pants (29.9%) had never used condoms and while the majority 
of participants (62.3%) reported having had one sexual partner 
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Table 1 STI prevalence and prevalence by sex
Overall Male Female
Any sTI prevalence (%) among participants (n/n, 95% CI)
Any STI 14.9 (71/478) 4.6 (9/195) 21.9 (62/283)
  11.79 to 18.36 2.10 to 8.58 17.23 to 27.19
sTI prevalence (%) by type among participants (n/n, 95% CI)
STI type
Ct 3.8 (18/478) 1.0 (2/195) 5.7(16/283)
2.22 - 5.89 0.12 - 3.66 3.27 - 9.01
Ng
  
3.8 (18/478) 3.6 (7/195) 3.9 (11/283)
2.25 to 5.89 1.47 to 7.26 1.96 to 6.85
Mg
  
1.9 (9/478) 0.5 (1/195) 2.8 (8/283)
0.86 to 3.54 0.01 to 2.82 1.22 to 5.49
Tv
  
5.9 (28/478) 0 (0/195) 9.9 (28/283)
3.93 to 8.36   6.68 to 13.98
Tp
  
0.8 (4/478) 0 (0/195) 1.4 (4/283)
0.23 to 2.12   0.39 to 3.58
Ct, Chlamydia trachomatis; Mg, Mycoplasma genitalium; Ng, Neisseria gonorrhoea; 
Tp, Treponema pallidum; Tv, Trichomonas vaginalis.
in the last year, 25.1% had more than one current partner. Char-
acteristics are further described in online supplementary mate-
rial, table S1.
sTI prevalence
A complete dataset was available for 478 participants. The prev-
alence of STI was 21.9% for women, which was significantly 
higher than 4.6% for men (table 1) (OR=5.81, 95% CI 2.82 to 
12.00, p<0.001). Even when HVS results were excluded and 
only prevalence of positive male and female urine samples were 
compared, women were still significantly more likely to have 
an STI (11.1% compared with 4.6%, OR 2.58, 95% CI 1.20 to 
5.56, p=0.015). No male samples were positive for Tv and, after 
excluding Tv from estimates, STI were still more common in 
women (OR=3.01, 95% CI 1.42 to 6.39, p=0.004).
Overall prevalence of STI by type was 5.9% for Tv, 3.8% for 
Ct and Ng, 1.9% for Mg and 0.8% for Tp. It is important to note 
that, unlike the molecular tests for other STI that detect current 
infection, the serological TPPA test for Tp cannot distinguish 
between current and previous infection or between syphilis and 
endemic treponematoses. It is therefore possible that the identi-
fied cases of Tp do not represent current infection with syphilis.
All STIs were more common in women. The prevalence of 
co- infection was 1.3% (6/478, 95% CI 0.46% to 2.71%): 2 Ct/
Mg, 1 Ct/Ng, 1 Ct/Tv, 1 Ng/Tv and 1 Ct/Tp. Five (83.3%) of 
these co- infections occurred in women. Only 3.2% (2/62) of 
women with an STI reported symptoms, which was no different 
to the 3.3% (7/214) of women without an STI who reported 
symptoms. Men with an STI were significantly more likely to 
report symptoms than women (22.2% compared with 3.2% (χ2 
(1, n=71)=5.33, p=0.021).
risk factors for sTI
A logistic regression model of STI infection status and village 
was non- significant (OR=0.97, 95% CI 0.92 to 1.03, p=0.33, 
n=488); therefore, multivariable regression did not require 
adjustment for the cluster sampling methodology.
Univariate analysis showed that age, sex and having concur-
rent partners were risk factors for STI. Having more than one 
partner in the last year also tended towards being a significant 
risk factor. Reporting optimal treatment of a previous STI 
(treated at a medical centre and partner treated) tended towards 
being a protective factor. Level of education, income, religion, 
marital status, age of sexual debut, previous STI, condom use, 
pregnancy and reporting of current symptoms of an STI were 
not significant risk factors.
Multivariable analysis showed that younger age, female sex 
and concurrent partnership were significant risk factors for 
STI. Having previously had an STI which was treated optimally 
(treated at a medical centre and partner treated) was a protective 
factor against being STI positive (table 2).
dIsCussIOn
Here, we report the first data on curable STI collected in the 
general population in Guinea Bissau. Our findings indicate the 
need for an STI control programme.
We found 14.9% of study participants to have one or multiple 
curable STI. One year prior to our study, azithromycin, an anti-
biotic that has activity against Ct, Ng, Mg and Tp, had been 
distributed to the population as part of an MDA programme for 
trachoma elimination.16 In the Solomon Islands, a similar MDA 
campaign resulted in a 40% reduction in age- adjusted urogen-
ital Ct prevalence.20 It is possible that STIs in our population 
have been similarly affected but unfortunately no data on STI 
prevalence prior to MDA is available for Bubaque. Longitudinal 
studies to assess changes in STI prevalence after MDA as well as 
azithromycin resistance patterns would be useful in character-
ising the impact of MDA in this context.
As would be expected, STI prevalence was mostly lower in 
our study than in previous studies from Guinea Bissau which 
estimated prevalence among individuals presenting to sexual 
health clinics. Prevalence of Ct, Mg and Tv among women in 
Bissau in our study was 5.7%, 2.8% and 9.9% compared with 
12.6%, 7.7% and 20.4% in a previous study on symptomatic 
women.10 In contrast, Ng prevalence was higher in our study 
(3.9% vs 1.3%) but this is likely explained by more sensitive 
diagnostics (PCR compared with bacterial culture) used in our 
work. Indeed, another study of people presenting to an STI 
clinic in Bissau found an Ng prevalence of 17% in women and 
38% in men,8 which is consistent with higher rates expected in 
those seeking medical assistance for symptoms. In an older study 
of women giving birth or aborting at the Simão Mendez Hospital 
in Bissau,11 Mg prevalence was higher than among women in our 
study (6.2% vs 2.8%). There may be a number of characteristics 
associated with attending the national referral hospital to give 
birth that explain this difference in results.
Although Tv was the most prevalent STI found in women, no 
cases were identified in male participants. Previous work from 
the Netherlands found Tv to be rare in men and not associated 
with symptoms.21 In contrast, a study from Mwanza showed it 
to be a common STI in symptomatic men.22 These contrasting 
findings are perhaps unsurprising given the different study popu-
lations. However, as infections are cleared quickly in men, Tv 
prevalence is likely to be low in unselected population studies 
such as ours.23
Tp was detected in only 0.8% of participants. Unlike molec-
ular tests used to detect current infection for the other STI, the 
TPPA test used to diagnose Tp infection does not distinguish 
between current and previous infection or between syphilis and 
endemic treponematoses. It is therefore possible that these cases 
of Tp were acquired in the past. This is consistent with the fact 
that, whereas other STI mostly occurred in younger age groups, 
all positive Tp results occurred in women over 30. Previous work 
in police officers in Bissau suggests a downward trend in Tp 
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Table 2 Independent risk factors for STI in univariate and multivariate models
risk factor Category n/n sTI positive (%) Or (95% CI) univariate analysis* P value Or (95% CI) multivariate analysis P value
Age (years) 16–19 27/140 19.3 2.14 (1.00 to 4.57) 0.022 2.88 (1.27 to 6.51)
20–25 19/120 15.8 1.44 (0.65 to 3.19) 1.89 (0.82 to 4.37) 0.005
26–35 13/112 11.6 0.99 (0.42 to 2.31) 1.21 (0.50 to 2.92)
36+ 12/106 11.3 1.0 1.0
Sex Female 62/283 21.9 5.80 (2.81 to 11.98) <0.001 14.06 (6.0 to 35.69) <0.001
Previous STI optimally treated Yes 2/38 5.3 0.27 (0.07 to 1.27) 0.082 0.20 (0.04 to 0.91) 0.038
Concurrent sexual partner Yes 18/120 15.0 4.56 (2.09 to 9.96) <0.001 7.69 (2.09 to 24.2) <0.001
Number of partners in 1 year 0 7/55 12.7 1.0 0.05 1.0 0.168
1 49/298 16.4 0.81 0.77 (0.30 to 1.99)
>1 15/108 13.9 2.65 0.38 (0.06 to 2.34)
Education None 12/58 20.7 1.0 0.684
Primary 14/119 11.8 0.55 (0.23 to 1.24)
Secondary 45/289 15.6 0.82 (0.36 to 1.87)
Tertiary 0/12 0 –
Income Yes 5/80 6 0.84 (0.30 to 2.35) 0.744
Religion None 30/166 18.1 1 0.337
Catholic 23/145 15.9 0.85 (0.45 to 1.59)
Protestant 17/98 17.4 1.27 (0.62 to 2.58)
Muslim 1/43 2.3 0.15 (0.02 to 1.14)
Married or living with partner Yes 63/355 17.8 0.84 (0.35 to 2.01) 0.703
Age of sexual debut<16 Yes 28/157 17.8 0.85 (0.55 to 1.32) 0.481
Previous STI Yes 11/91 12.1 1.10 (0.53 to 2.27) 0.807
Condom use Never 19/143 13.3 1 0.462
Sometimes 35/174 20.1 1.49 (0.78 to 2.85)
Usually 4/29 13.8 1.33 (0.40 to 4.47)
Often 13/75 17.3 1.40 (0.61 to 3.23)
Number of pregnancies 0 18/66 27.3 1 0.537
1 23/97 23.7 0.92 (0.42 to 2.02)
2 to 4 12/60 20.0 0.85 (0.28 to 2.61)
>4 9/60 15.0 0.65 (0.17 to 2.44)
Pregnant at time of study Yes 9/61 14.8 0.56 (0.26 to 1.22) 0.143
Current STI symptoms Yes 4/19 21.1 1.85 (0.55 to 6.21) 0.317
*For all other variables, the regression was adjusted for age and sex.
STI, sexually transmitted infection.
prevalence from 4.5% in 1990 to 0.4% in 2010.12 Older women 
might have a residual positive TPPA test having acquired syphilis 
prior to a decline in prevalence or from exposure to yaws in 
childhood.
In our study, even after exclusion of Tv, being female was 
a significant risk factor for STI. This is a widely recognised 
phenomenon1 24 25 with a number of explanations. In other 
contexts, gender power imbalances prevent women from nego-
tiating safe sex24 but in a matriarchal society, where women can 
make decisions about relationships,14 15 this is less likely to be a 
factor. On the other hand, having the power to change partner 
might increase the number of partners a woman has and there-
fore the risk of STI. A further reason is that women are more 
susceptible to pathogen entry due to greater trauma over a larger 
mucosal area during sex.26 Finally, higher rates of asymptomatic 
infections are likely to contribute to higher prevalence of STI 
in women. In this study, women with an STI were significantly 
less likely to report symptoms than men. Indeed, even after 
prompting with a description of potential symptoms, 97% of 
women found to have an STI denied having symptoms. The 
standard syndromic management approach used in this context 
would not detect these cases. This highlights the urgent need 
for cheap and practical screening methods to detect asympto-
matic STI as untreated infections can result in severe sequelae 
and contribute to ongoing transmission.4
Younger age was also a risk factor for STI. Young people 
often engage in greater risk- taking behaviour and, in women, a 
less mature cervix allows for easier pathogen entry.27 Concur-
rent partnership is another risk factor that has previously been 
well described.28 Reporting having had a previous STI that was 
medically treated had no relationship with current risk of STI. 
However, if partners had also been treated, the risk of current STI 
was reduced. This supports the importance of partner notification 
strategies in breaking the cycle of STI transmission.29 Surprisingly, 
condom use was not associated with lower risk of STI although 
inconsistent or incorrect use may explain this result.30
Potential limitations of this study should be noted. First, 
Bubaque may not be representative of the region as a whole. 
Furthermore, sampling was done by household and prevalence 
may therefore be overestimated. If one member of a household 
had an STI, their included partner would also be more likely to 
have an STI. 32.8% of participants reported sexual debut under 
the age of 16 but under- 16s were not eligible for inclusion, 
meaning data from this potentially important group is lacking. 
Although participant numbers were sufficient to determine 
prevalence and identify certain risk factors for STI, the study 
was likely underpowered to detect all relevant factors. Finally, 
questionnaire data are limited by recall bias and some answers 
may not have been truthful. Indeed 5 of 39 people who reported 
never having had sex tested positive for an STI.
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In conclusion, this is the first study to document the preva-
lence of curable STI in a general population in this region. An 
estimated prevalence of 14.9% shows that STI are an important 
problem on Bubaque. We find that younger age, female sex and 
having multiple concurrent partners are significant risk factors 
for STI and our data demonstrate the importance of partner 
notification in reducing the risk of STI. We show that, in this 
context, most people with an STI do not report symptoms even 
after prompting. In the absence of screening programmes for 
asymptomatic infections, their STI would not be detected or 
treated, placing them at risk of developing complications and 
continuing the spread of infection. This indicates the need for 
accurate diagnostic methods that can help to detect and treat 
asymptomatic infections through the development of a national 
STI control programme. Overall, our results demonstrate a need 
for a national STI control programme in Guinea Bissau and pave 
the way for further epidemiological work to develop this.
Key messages
 ► Sexually transmitted infections (STI) are a significant problem 
on Bubaque Island and an STI control strategy is needed.
 ► Women on Bubaque Island are disproportionately affected 
by STI.
 ► Most people with an STI do not report symptoms, indicating 
the need for feasible screening methods to detect and treat 
asymptomatic infections.
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